• BX Home
  • Merck & Co.: News [Page 2]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MERCK & CO.

Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.

Merck & Co. is part of Business Exchange, suggested by Ginny Moore. This topic contains 969 news and 178 blog items. Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from like-minded professionals.

News

Please add new articles to this topic

Merck Leads Stocks Lowermore

Extract not available.

China���s Cancer Deaths Spur Merck Investment in Beijing Biotechmore

demand for treatments. BeiGene Ltd. hired 20 U.S.-educated scientists from companies including Johnson & Johnson...

Arthritis Drug���s $1.4 Billion Promise for 4SC Hinges on Studymore

from Abbott Park, Illinois-based Abbott Laboratories; and Remicade, sold by New Brunswick, New Jersey-based Johnson...

DJIA at 115 Years: How It Has Told the American Storymore

Extract not available.

BioCryst Pharmaceuticals Announces Appointment Of Thomas Staab As Its ...more

Executive Vice President, CFO and Treasurer of Inspire Pharmaceuticals from May 2003 through its $430 million...

Approval of Hepatitis C drug promises more curesmore

rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from...

Vertex���s Sales Force Gears Up For ���David vs. Goliath��� Marketing ...more

Extract not available.

���Pay for Delay��� Drug Deals Should Be Halted, FTC Tells Courtmore

the U.S. Court of Appeals in Philadelphia to reverse a lower court���s ruling that accords between Merck & Co.

Business news in briefmore

from hepatitis C who either have not been treated or were not cured by other drugs. Incivek and Merck & Co.

PhillyInc: When local grads stay and clean upmore

great, and Emcor is nonexistent or OK where USM is great." Annual meetings Tuesday: Healthcare Services Group,...

UPDATE 1-Adcock H1 profit flat, eyes more Africa expansionmore

items. Adcock finalised the acquisition Ghana's Ayrton during the period and teamed up with U.S. firm Merck & Co...

Second Drug Wins Approval For Treatment of Hepatitis Cmore

Pharmaceuticals won regulatory approval on Monday for a new hepatitis C drug, setting off a marketing battle with Merck...

Merck Announces Third Quarter 2011 Dividendmore

Stock quotes in this article:MRK At their meeting today, the Board of Directors of Merck (NYSE: MRK), known as MSD...

UPDATE 2-Adcock mulls Nigeria expansion, H1 profit flatmore

Ghana's Ayrton last year and increased its pipeline of drugs by teaming up with U.S. firm Merck & Co (MRK.

A.M. Vitals: Vertex, J&J Hepatitis C Drug Wins FDA Approvalmore

Extract not available.

Vertex hepatitis C drug OK'd, promising more curesmore

rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from...

J&J AIDS Pill Signals $9 Billion in Sales to Ease Recall Woesmore

the most exciting in the industry��� and should help it outpace profit growth at drugmakers including Pfizer Inc.

J&J AIDS Pill Signals $9B in Revenue to Ease Recallsmore

the most exciting in the industry��� and should help it outpace profit growth at drugmakers including Pfizer Inc.

Vertex hepatitis C drug approved, promising more curesmore

of treatment for the liver-destroying condition and setting up a head-to-head marketing battle with a rival medicine...

Big Pharma follows broader market southmore

the mid-sized caps, shares of Parexel International (NASDAQ:PRXL) Vertex Pharmaceuticals (NASDAQ:VRTX) Incivek will...

Second Entry Wins Approval as Hepatitis C Drugmore

Pharmaceuticals won regulatory approval on Monday for a new hepatitis C drug, setting off a marketing battle with Merck...

UPDATE 2-Vertex hepatitis C drug wins U.S. approvalmore

after an FDA advisory panel unanimously recommended the drug last month. The agency approved another hepatitis C drug,...

Vertex hepatitis C drug wins U.S. approvalmore

after an FDA advisory panel unanimously recommended the drug last month. The agency approved another hepatitis C drug,...

FDA clears Vertex's hepatitis C drug Incivekmore

intravenous therapies. The Cambridge, Mass., company has already started promoting the drug in advance of approval.

FDA Approves Vertex's Hep C Drugmore

More from Adam Feuerstein Biotech Stock Mailbag: Live ChatEuropean Regulators Approve New Drugs Market Activity Vertex...

Top Sources: Merck & Co.

  • Reuters
  • BusinessWeek
  • Philadelphia Inquirer
  • MarketWatch
  • Wall Street Journal Online
  • Financial Times
  • businesswire.com
  • Forbes.com
  • latimes.com
  • inpharm.com

Most Active Users in this Topic

see all contributors in Merck & Co.

Featured White Papers

Post a Job

Jobs in this Topic

Senior Scientist Merck & Co | Rahway, NJ
Posted: May 17
Sovereign/Merck Employees Only Job Alliedbarton | North Wales, PA
Posted: May 13
Maintenance Supervisor Merck & Co | Millsboro, DE
Posted: May 15
Security - Current Sovereign/Merck Employees apply here Job Alliedbarton | West Point, PA
Posted: Apr 17
Medical Communications Co-op Job Merck & Co | Lansdale, PA
Posted: May 13

Report comment contains invalid characters. ()
cancel
Search Cancel